Elevated Liver Enzymes: Diagnosis and Management

Introduction to Liver Enzyme Elevation

A normal AST with sharply rising ALT is highly specific for acute hepatocellular injury and most commonly indicates nonalcoholic fatty liver disease (NAFLD), viral hepatitis, or medication-induced liver injury 1, 2
ALT is the most liver-specific enzyme because it exists primarily in hepatocytes with minimal presence in cardiac muscle, skeletal muscle, or red blood cells, making isolated ALT elevation highly indicative of hepatocellular damage rather than injury to other organs 1, 2

NAFLD is the leading cause of isolated transaminase elevation in developed countries, affecting 20-30% of the general population and up to 70% in obese individuals, typically presenting with an AST:ALT ratio <1 2, 3
Viral hepatitis causes ALT elevation that can be disproportionate to AST, particularly in early phases of infection or during reactivation 2, 3
Medication-induced liver injury accounts for 8-11% of cases with elevated liver enzymes and commonly presents with predominant ALT elevation in the hepatocellular injury pattern 1, 2

The degree of ALT elevation determines management urgency, with mild elevation (<5× upper limit of normal [ULN]) requiring repeat testing in 2-4 weeks, moderate elevation (5-10× ULN) requiring prompt but not emergent evaluation, and severe elevation (>10× ULN) requiring urgent hepatology referral 1, 2
For women, normal ALT is 19-25 IU/L, making even modest elevations more clinically significant than in men (29-33 IU/L) 1

Obtain a complete liver panel, viral hepatitis serologies, metabolic parameters, creatine kinase, and thyroid function tests to identify the underlying cause 1, 2
Abdominal ultrasound is the recommended initial imaging test, with 84.8% sensitivity and 93.6% specificity for detecting moderate to severe hepatic steatosis 1, 2

Immediate referral is indicated if ALT increases to >5× ULN, bilirubin increases to >2× ULN, evidence of synthetic dysfunction, or ALT remains elevated for ≥6 months without identified cause 1, 2, 3, 4
Calculate the FIB-4 score using age, ALT, AST, and platelet count to determine need for hepatology referral, with a score >2.67 indicating high risk for advanced fibrosis 1, 2, 3, 4